Leukapheresis Market By Product, By Method, By Application, By End User: Global Opportunity Analysis and Industry Forecast, 2021-2031

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO Perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. COVID-19 Impact Analysis on the market

CHAPTER 4: LEUKAPHERESIS MARKET, BY PRODUCT
4.1 Overview
4.1.1 Market size and forecast
4.2 Devices
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Disposables
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country

CHAPTER 5: LEUKAPHERESIS MARKET, BY METHOD
5.1 Overview
5.1.1 Market size and forecast
5.2 Centrifugation
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Membrane Separation
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Selective Adsorption
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country

CHAPTER 6: LEUKAPHERESIS MARKET, BY APPLICATION
6.1 Overview
6.1.1 Market size and forecast
6.2 Therapeutic Applications
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Research Applications
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country

CHAPTER 7: LEUKAPHERESIS MARKET, BY END USER
7.1 Overview
7.1.1 Market size and forecast
7.2 Blood Centers
7.2.1 Key market trends, growth factors and opportunities
7.2.2 Market size and forecast, by region
7.2.3 Market analysis by country
7.3 Hospitals
7.3.1 Key market trends, growth factors and opportunities
7.3.2 Market size and forecast, by region
7.3.3 Market analysis by country
7.4 Others
7.4.1 Key market trends, growth factors and opportunities
7.4.2 Market size and forecast, by region
7.4.3 Market analysis by country

CHAPTER 8: LEUKAPHERESIS MARKET, BY REGION
8.1 Overview
8.1.1 Market size and forecast
8.2 North America
8.2.1 Key trends and opportunities
8.2.2 North America Market size and forecast, by Product
8.2.3 North America Market size and forecast, by Method
8.2.4 North America Market size and forecast, by Application
8.2.5 North America Market size and forecast, by End User
8.2.6 North America Market size and forecast, by country
8.2.6.1 U. S.
8.2.6.1.1 Market size and forecast, by Product
8.2.6.1.2 Market size and forecast, by Method
8.2.6.1.3 Market size and forecast, by Application
8.2.6.1.4 Market size and forecast, by End User
8.2.6.2 Canada
8.2.6.2.1 Market size and forecast, by Product
8.2.6.2.2 Market size and forecast, by Method
8.2.6.2.3 Market size and forecast, by Application
8.2.6.2.4 Market size and forecast, by End User
8.2.6.3 Mexico
8.2.6.3.1 Market size and forecast, by Product
8.2.6.3.2 Market size and forecast, by Method
8.2.6.3.3 Market size and forecast, by Application
8.2.6.3.4 Market size and forecast, by End User
8.3 Europe
8.3.1 Key trends and opportunities
8.3.2 Europe Market size and forecast, by Product
8.3.3 Europe Market size and forecast, by Method
8.3.4 Europe Market size and forecast, by Application
8.3.5 Europe Market size and forecast, by End User
8.3.6 Europe Market size and forecast, by country
8.3.6.1 Germany
8.3.6.1.1 Market size and forecast, by Product
8.3.6.1.2 Market size and forecast, by Method
8.3.6.1.3 Market size and forecast, by Application
8.3.6.1.4 Market size and forecast, by End User
8.3.6.2 France
8.3.6.2.1 Market size and forecast, by Product
8.3.6.2.2 Market size and forecast, by Method
8.3.6.2.3 Market size and forecast, by Application
8.3.6.2.4 Market size and forecast, by End User
8.3.6.3 UK
8.3.6.3.1 Market size and forecast, by Product
8.3.6.3.2 Market size and forecast, by Method
8.3.6.3.3 Market size and forecast, by Application
8.3.6.3.4 Market size and forecast, by End User
8.3.6.4 Italy
8.3.6.4.1 Market size and forecast, by Product
8.3.6.4.2 Market size and forecast, by Method
8.3.6.4.3 Market size and forecast, by Application
8.3.6.4.4 Market size and forecast, by End User
8.3.6.5 Spain
8.3.6.5.1 Market size and forecast, by Product
8.3.6.5.2 Market size and forecast, by Method
8.3.6.5.3 Market size and forecast, by Application
8.3.6.5.4 Market size and forecast, by End User
8.3.6.6 Rest of Europe
8.3.6.6.1 Market size and forecast, by Product
8.3.6.6.2 Market size and forecast, by Method
8.3.6.6.3 Market size and forecast, by Application
8.3.6.6.4 Market size and forecast, by End User
8.4 Asia-Pacific
8.4.1 Key trends and opportunities
8.4.2 Asia-Pacific Market size and forecast, by Product
8.4.3 Asia-Pacific Market size and forecast, by Method
8.4.4 Asia-Pacific Market size and forecast, by Application
8.4.5 Asia-Pacific Market size and forecast, by End User
8.4.6 Asia-Pacific Market size and forecast, by country
8.4.6.1 Japan
8.4.6.1.1 Market size and forecast, by Product
8.4.6.1.2 Market size and forecast, by Method
8.4.6.1.3 Market size and forecast, by Application
8.4.6.1.4 Market size and forecast, by End User
8.4.6.2 China
8.4.6.2.1 Market size and forecast, by Product
8.4.6.2.2 Market size and forecast, by Method
8.4.6.2.3 Market size and forecast, by Application
8.4.6.2.4 Market size and forecast, by End User
8.4.6.3 India
8.4.6.3.1 Market size and forecast, by Product
8.4.6.3.2 Market size and forecast, by Method
8.4.6.3.3 Market size and forecast, by Application
8.4.6.3.4 Market size and forecast, by End User
8.4.6.4 Australia
8.4.6.4.1 Market size and forecast, by Product
8.4.6.4.2 Market size and forecast, by Method
8.4.6.4.3 Market size and forecast, by Application
8.4.6.4.4 Market size and forecast, by End User
8.4.6.5 South Korea
8.4.6.5.1 Market size and forecast, by Product
8.4.6.5.2 Market size and forecast, by Method
8.4.6.5.3 Market size and forecast, by Application
8.4.6.5.4 Market size and forecast, by End User
8.4.6.6 Rest of Asia-Pacific
8.4.6.6.1 Market size and forecast, by Product
8.4.6.6.2 Market size and forecast, by Method
8.4.6.6.3 Market size and forecast, by Application
8.4.6.6.4 Market size and forecast, by End User
8.5 LAMEA
8.5.1 Key trends and opportunities
8.5.2 LAMEA Market size and forecast, by Product
8.5.3 LAMEA Market size and forecast, by Method
8.5.4 LAMEA Market size and forecast, by Application
8.5.5 LAMEA Market size and forecast, by End User
8.5.6 LAMEA Market size and forecast, by country
8.5.6.1 Brazil
8.5.6.1.1 Market size and forecast, by Product
8.5.6.1.2 Market size and forecast, by Method
8.5.6.1.3 Market size and forecast, by Application
8.5.6.1.4 Market size and forecast, by End User
8.5.6.2 Saudi Arabia
8.5.6.2.1 Market size and forecast, by Product
8.5.6.2.2 Market size and forecast, by Method
8.5.6.2.3 Market size and forecast, by Application
8.5.6.2.4 Market size and forecast, by End User
8.5.6.3 South Africa
8.5.6.3.1 Market size and forecast, by Product
8.5.6.3.2 Market size and forecast, by Method
8.5.6.3.3 Market size and forecast, by Application
8.5.6.3.4 Market size and forecast, by End User
8.5.6.4 Rest of LAMEA
8.5.6.4.1 Market size and forecast, by Product
8.5.6.4.2 Market size and forecast, by Method
8.5.6.4.3 Market size and forecast, by Application
8.5.6.4.4 Market size and forecast, by End User

CHAPTER 9: COMPANY LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Key developments

CHAPTER 10: COMPANY PROFILES
10.1 Adacyte Therapeutics
10.1.1 Company overview
10.1.2 Company snapshot
10.1.3 Operating business segments
10.1.4 Product portfolio
10.1.5 Business performance
10.1.6 Key strategic moves and developments
10.2 AllCells, LLC.
10.2.1 Company overview
10.2.2 Company snapshot
10.2.3 Operating business segments
10.2.4 Product portfolio
10.2.5 Business performance
10.2.6 Key strategic moves and developments
10.3 Asahi Kasei Corporation
10.3.1 Company overview
10.3.2 Company snapshot
10.3.3 Operating business segments
10.3.4 Product portfolio
10.3.5 Business performance
10.3.6 Key strategic moves and developments
10.4 Charles River Laboratories International, Inc.
10.4.1 Company overview
10.4.2 Company snapshot
10.4.3 Operating business segments
10.4.4 Product portfolio
10.4.5 Business performance
10.4.6 Key strategic moves and developments
10.5 Cerus Corporation
10.5.1 Company overview
10.5.2 Company snapshot
10.5.3 Operating business segments
10.5.4 Product portfolio
10.5.5 Business performance
10.5.6 Key strategic moves and developments
10.6 Fresenius Kabi
10.6.1 Company overview
10.6.2 Company snapshot
10.6.3 Operating business segments
10.6.4 Product portfolio
10.6.5 Business performance
10.6.6 Key strategic moves and developments
10.7 Haemonetics Corporation
10.7.1 Company overview
10.7.2 Company snapshot
10.7.3 Operating business segments
10.7.4 Product portfolio
10.7.5 Business performance
10.7.6 Key strategic moves and developments
10.8 Macopharma
10.8.1 Company overview
10.8.2 Company snapshot
10.8.3 Operating business segments
10.8.4 Product portfolio
10.8.5 Business performance
10.8.6 Key strategic moves and developments
10.9 SB-Kawasumi Laboratories, Inc.
10.9.1 Company overview
10.9.2 Company snapshot
10.9.3 Operating business segments
10.9.4 Product portfolio
10.9.5 Business performance
10.9.6 Key strategic moves and developments
10.10 Terumo BCT, Inc.
10.10.1 Company overview
10.10.2 Company snapshot
10.10.3 Operating business segments
10.10.4 Product portfolio
10.10.5 Business performance
10.10.6 Key strategic moves and developments

Executive Summary

According to this report, titled, 'Leukapheresis Market,' the leukapheresis market size was valued at $245.65 million in 2021, and is estimated to reach $561.6 million by 2031, growing at a CAGR of 8.6% from 2022 to 2031.

Leukapheresis is used to separate leukocytes from peripheral blood. It is a type of apheresis used to remove leukocytes and re-infuse plasma deficient in leukocytes. After the removal of white blood cells, remaining components are then returned to the donor or patient either during the process or at the end of the process. It is used to treat chronic lymphocytic leukemia (CLL) or patients with very high white blood cell counts.

Leukapheresis is the choice of treatment for patients suffering from leukemia as in few cases chemotherapy may not lower the number of cells until a few days after the first dose. Thus, with increase in number of leukemia patients across the globe, leukapheresis is expected to gain traction in the future. For instance, according to the North American Association of Central Cancer Registries (NAACCR), the U.S. is estimated to record 6,660 cases of acute lymphocytic leukemia in 2022.

The leukapheresis market trends include, increase in demand for leukapheresis in developed countries such as the U.S. Moreover, rise in prevalence of chronic diseases such as leukemia also propel the market growth. In addition, rise in demand and adoption of leukopaks in various applications such as R&D activities further drives the market growth.

Furthermore, rise in government initiatives that promote blood donations in developing countries such as China and India propel the market growth during leukapheresis market forecast. For instance, Twitter launched a social initiative called BloodMatters in India in March 2018. It collaborated with the voluntary blood donation helpline named Blood Donors.

The COVID-19 outbreak is anticipated to have a positive impact on growth of the global leukapheresis market. The leukapheresis industry was benefited from the COVID-19, as the vaccines which were undergoing clinical testing included the research on white blood cells. This research was the crucial part in the creation of new vaccinations.

Additionally, research is being done to determine how COVID-19 affects white blood cells. For instance, in order to comprehend how SARS-CoV-2 affects lymphocytes, the NIH (National Institute of Health) is carrying out clinical trials that call for leukapheresis. In addition, regularization of supply chain of medications by key players and rise in the number of patient visits for investigation and treatment anticipated to fuel the growth of leukapheresis market after COVID-19 pandemic.

The leukapheresis market size is segmented on the basis of product, method, application, end user and region. By product, the market is segmented into devices and disposables. The disposables segment exhibited highest growth in 2021, and is expected to remain dominant during the forecast period, owing to rise in demand for leukapheresis procedures for isolation of white blood cells, which requires disposables. For instance, Terumo BCT, Inc. manufactures cost-effective blood bags while maintaining efficacy and quality of the bags. In addition, increase in prevalence of leukemia leads to rise in demand for leukapheresis disposables, which further boosts the segment growth.

On the basis of method, the market is segmented into centrifugation, membrane separation, and selective adsorption. The centrifugation segment exhibited highest leukapheresis market share in 2021, owing to the fact that centrifugation is considered to be a standard method for leukapheresis and is highly favored by the blood industry across the globe.

However, the membrane separation segment is projected to register highest CAGR during the forecast period. This is attributed to rise in demand for membrane separation leukapheresis as it prevents the need for replacement fluids by not depleting the blood coagulation factors boost the market growth during leukapheresis market analysis.

On the basis of application, the market is segmented into therapeutics application and research application. The therapeutics application segment dominated the market in 2021. This was attributed to rise in demand for leukapheresis procedure as it removes the excess white blood cells. Moreover, the research application segment is projected to register a highest CAGR during the forecast period, owing to rise in R&D activities for cancer leads to increases the demand for leukopak in clinical trial.

On the basis of end user, the market is segmented into blood centers, hospitals and others. Others segment further includes research institutes, biopharmaceutical manufacturers, and private medical settings. The blood centers segment dominated the market in 2021. This was attributed to increase in number of blood centers across the globe. In addition, increase in number of blood donations, which lead to increase in number of blood centers in the country.

Moreover, the others segment is projected to register highest CAGR during the forecast period, owing to increasing research studies in research institutes which is focused on white blood cells to treat diseases such as cancer.

North America accounted for the largest leukapheresis market share of the global leukapheresis market in 2021, owing to high incidences of leukemia and rise in infrastructure. In addition, rise in technological innovations for leukapheresis devices and increase in awareness regarding blood donation further drive the market growth in this region.

However, Asia-Pacific is expected to fastest CAGR during the forecast period, owing to factors such as rise in investments in manufacturing of high-quality leukapheresis devices and disposables. In addition, increase in healthcare infrastructure in this region further propel the market growth.

KEY FINDINGS OF THE STUDY

• Based on type, the disposables segment held largest share in the leukapheresis industry in 2021.
• On the basis of method, the centrifugation segment held largest market share in 2021. However, membrane separation segment is anticipated to grow at the highest CAGR during the forecast period.
• Based on application, therapeutics application segment dominated the market in 2021. However, research application segment is expected to register highest CAGR ofduring the forecast period.
• On the basis of end user, blood centers segment dominated the market in 2021. However, others segment is anticipated to grow at the highest CAGR during the forecast period.
• On the basis of region, North America held largest share in the global market in 2021. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.

Companies Mentioned

• Adacyte Therapeutics
• Allcells, LLC.
• Asahi Kasei Corporation
• Charles River Laboratories International, Inc.
• Cerus Corporation
• Fresenius Kabi
• Haemonetics Corporation
• Macopharma
• Sb-Kawasumi Laboratories, Inc.
• Terumo Bct, Inc.

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

• Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
• Scientific and technical writings for product information and related preemptions
• Regional government and statistical databases for macro analysis
• Authentic news articles and other related releases for market evaluation
• Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.